Recent Updates
Recently added Catalysts
ATHE Neutral Sentiment Score: 60/100

Appendix 2A - Application for quotation of securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Friday July 19 , 2024 The +securities to b

Key Takeaway: Alterity Therapeutics Limited has announced the application for the quotation of 75,220,800 fully paid ordinary shares. This issuance is part of a transaction previously detailed in an Appendix 3B submission. The new securities are part of an overall capital strategy, with the issued capital amounting to over 5.3 billion ordinary shares following the quotation. The announcement was made on July 19, 2024, indicating ongoing activities in the company’s financial maneuvers.

Market Sentiment Analysis

POSITIVE FACTORS

  • Alterity Therapeutics is issuing a substantial number of new securities.
  • The securities are fully paid which could strengthen the company's financial position.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Friday July 19, 2024
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions
previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
ASX +security code +Security description Number of +securities to be quoted Issue date
ATH ORDINARY FULLY PAID 75,220,800 18/07/2024
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of the
following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type Registration number
ABN 37080699065
Date of this announcement
Part 2 - Type of Issue
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions
previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
Announcement Date and Time Announcement Title Selected Appendix 3B to submit quotation request
18-Jul-2024 12:16 New - Proposed issue of securities - ATH A placement or other type of issue
2.3a.2 Are there any further issues of +securities
yet to take place to complete the transaction(s) referred to in the Appendix 3B?
Part 3A - number and type of
+securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
code and description
ATH : ORDINARY FULLY PAID
Distribution Schedule
Provide a distribution schedule for the new +securities
according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities
held by the recipients in each category.
Number of +securities held Number of holders Total percentage of +securities held For example, to enter a value of 50% please input as 50.00
1 - 1,000 %
1,001 - 5,000 %
5,001 - 10,000 %
10,001 - 100,000 %
100,001 and over %
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
In what currency is the cash consideration being paid? What is the issue price per +security?
AUD - Australian Dollar AUD 0.00540000
Any other information the entity wishes to provide about the +securities to be quoted
Part 4 - Issued capital following quotation
Following the quotation of the +securities the subject
of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically
generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently
with ASX for processing.
Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the
+securities subject of this application)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 5,320,336,118
ATHO : OPTION EXPIRING 31-AUG-2026 932,706,668
Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAI : OPTION EXPIRING 31-AUG-2024 EX $0.007 1,935,759,704
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 14,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 26,500,000
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720

Frequently Asked Questions

What is the ASX security code for Alterity Therapeutics?

The ASX security code for Alterity Therapeutics is ATH.

How many securities are being quoted by Alterity Therapeutics?

A total of 75,220,800 securities are being quoted.

What is the issue price per security for the new issuance?

The issue price per security is AUD 0.0054.

When were the new securities issued?

The new securities were issued on July 18, 2024.

What is the total issued capital after the new quotation?

Following the quotation, the total issued capital will be 5,320,336,118.

Last updated: Jul 19, 2024